CA Patent

CA2993615A1 — Methods of preparing 6-(aryl or heteroaryl)-1,3,5-triazine-2,4-diols and 6-(aryl or heteroaryl)-1,3,5-triazine-2,4-diamines

Assigned to Agios Pharmaceuticals Inc · Expires 2017-02-09 · 9y expired

What this patent protects

Provided are methods of preparing compounds of formula (VIII) useful for treating cancer and intermediates of formula (I)

USPTO Abstract

Provided are methods of preparing compounds of formula (VIII) useful for treating cancer and intermediates of formula (I)

Drugs covered by this patent

Patent Metadata

Patent number
CA2993615A1
Jurisdiction
CA
Classification
—
Expires
2017-02-09
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.